tradingkey.logo
tradingkey.logo
Pesquisar

Niagen Bioscience Inc

NAGE
Adicionar à lista de desejos
3.430USD
+0.100+3.00%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
273.42MValor de mercado
14.69P/L TTM

Mais detalhes de Niagen Bioscience Inc Empresa

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Informações de Niagen Bioscience Inc

Código da empresaNAGE
Nome da EmpresaNiagen Bioscience Inc
Data de listagemJun 25, 2007
CEOFried (Robert N)
Número de funcionários104
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 25
Endereço10900 Wilshire Blvd Suite 600
CidadeLOS ANGELES
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal90024
Telefone13103886706
Sitehttps://www.niagenbioscience.com/
Código da empresaNAGE
Data de listagemJun 25, 2007
CEOFried (Robert N)

Executivos da empresa Niagen Bioscience Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ozan Pamir
Mr. Ozan Pamir
Chief Financial Officer
Chief Financial Officer
9.59K
+23.15%
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Lead Independent Director
Lead Independent Director
7.00K
--
Mr. Carlos Luis Lopez
Mr. Carlos Luis Lopez
Senior Vice President, General Counsel
Senior Vice President, General Counsel
2.25K
--
Mr. Frank L. Jaksch, Jr.
Mr. Frank L. Jaksch, Jr.
Chairman of the Board
Chairman of the Board
--
--
Mr. Robert N. (Rob) Fried
Mr. Robert N. (Rob) Fried
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Wendy Yu
Ms. Wendy Yu
Independent Director
Independent Director
--
--
Mr. Gary Ng
Mr. Gary Ng
Independent Director
Independent Director
--
--
Ms. Kristin Patrick
Ms. Kristin Patrick
Independent Director
Independent Director
--
--
Ms. Ann Cohen
Ms. Ann Cohen
Independent Director
Independent Director
--
--
Mr. Hamed Shahbazi
Mr. Hamed Shahbazi
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ozan Pamir
Mr. Ozan Pamir
Chief Financial Officer
Chief Financial Officer
9.59K
+23.15%
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Lead Independent Director
Lead Independent Director
7.00K
--
Mr. Carlos Luis Lopez
Mr. Carlos Luis Lopez
Senior Vice President, General Counsel
Senior Vice President, General Counsel
2.25K
--
Mr. Frank L. Jaksch, Jr.
Mr. Frank L. Jaksch, Jr.
Chairman of the Board
Chairman of the Board
--
--
Mr. Robert N. (Rob) Fried
Mr. Robert N. (Rob) Fried
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Wendy Yu
Ms. Wendy Yu
Independent Director
Independent Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Niagen Bioscience Inc?

Os cinco principais acionistas de Niagen Bioscience Inc são: Mr. Ozan Pamir